drugset / Trial / NCT01011114
Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine whether cinacalcet, used in patients with secondary hyperparathyroidism to control excessive parathyroid hormone, can normalize low blood phosphorus that is commonly seen in patients who have had a kidney transplant.
Timeline
- Start
- 2009-11
- Primary completion
- 2015-10-15
- Completion
- 2015-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cinacalcet | Other / unclassified | 30 mg | — |